![]() |
In association with
|
|
Forward to a colleague |
||
Access Full Stories While GSK, AstraZeneca and Eli Lilly have hit the headlines in the UK Serious Fraud Office's (SFO) investigation into illegal bribes paid to Saddam Hussein's Iraqi regime, many more pharma firms are on the organisation's... Read Merck divests API plant; hands out large contract Merck & Co has handed the reins of one of its US active pharmaceutical ingredient (API) manufacturing facilities over to new a owner, who has also secured a lucrative contract manufacturing deal with the drug... Read A drug cocktail to bust brain tumours A team of US researchers have uncovered a cocktail of three drugs that could be effective at treating every patient with a particular type of brain cancer that typically has a dismal prognosis... Read Pharmaceutical manufacturing: people on the move Applied Biosystems, Pharmos, Pearl Therapeutics, Pacira Pharmaceuticals and Covance have all had people on the move in the world of pharmaceutical manufacturing... Read New company formed for drug delivery tech Jerusalem-based Yissum has formed a spin-off company Nanolymf, which will be dedicated to advancing a nanotechnology controlled-release drug delivery platform... Read |
|||||||||||||||||
All News Headlines for: January | December | November |
|||||||||||||||||
|
Related Industry News New drug target leaves lung cancer cells alone, lonely and dying It seems even tumour cells can get lonely; scientists have discovered that by cutting off a key gene, lung cancer tumour cells are left 'homeless' and they can't survive on their own... Read Quintiles in $3bn investment deal One Equity Partners (OEP), the private equity arm of JPMorgan Chase, is in the process of selling its stake in Quintiles for a reported sum of over $3bn... Read Small molecules still leading the way into the clinic DrugResearcher.com brings you its annual round up of all the drugs that entered clinical development in 2007... Read Two dimensions are better than one when profiling metabolites US researchers have shown that 2D NMR (nuclear magnetic resonance) experiments can greatly enhance the ability of metabolic profiling to quantify disease identification and progression... Read
|
|||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||